IP Library Patent Application 15257318
Patent Application
App. No. 15/257,318

Skin Solution with Solubilized Bakuchiol

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/257,318
Abstract

A composition for the treatment of acne includes hydrolyzed Psoralea corylifolia , containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In various implementations, the composition is a water-based acne gel or a water-based cleanser. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid, benzoyl peroxide, tretinoin, retinol, tazarotene, or an antibiotic, or a combination of these. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Claims (48)

1 . A method of preparing an aqueous mixture comprising:

mixing deionized water and hydroxyethylcellulose to obtain a first mixture;

applying heat to the first mixture until the first mixture reaches about 75 degrees Celsius;

adding disodium ethylenediaminetetraacetic acid (EDTA) and sodium pyrrolidone carboxylic acid (PCA) to the first mixture and mixing to obtain a second mixture;

allowing the second mixture to cool to from about 60 to 65 degrees Celsius;

mixing butylene glycol and salicylic acid to obtain a third mixture;

applying heat to the third mixture until the third mixture reaches about 65 degrees Celsius;

mixing the third mixture and second mixture together to obtain a fourth mixture;

allowing the fourth mixture to cool to from about 55 to 60 degrees Celsius;

adding glycolic acid and lactic acid to the fourth mixture and mixing to obtain a fifth mixture;

allowing the fifth mixture to cool to from about 50 to 55 degrees Celsius;

mixing deionized water and sodium hydroxide to obtain a sixth mixture;

mixing the sixth mixture and the fifth mixture together to obtain a seventh mixture;

allowing the seventh mixture to cool to from about 45 to 50 degrees Celsius;

mixing deionized water and perilla ocymoides leaf extract to obtain an eighth mixture;

mixing the eighth mixture and the seventh mixture to obtain a ninth mixture;

mixing deionized water and olea europaea fruit extract to obtain a tenth mixture;

mixing the tenth mixture and ninth mixture to obtain an eleventh mixture;

allowing the eleventh mixture to cool to from about 40 to 45 degrees Celsius;

adding sodium benzoate to the eleventh mixture and mixing to obtain a twelfth mixture;

solubilizing an unsolubilized hydrolyzed Psoralea corylifolia extract to obtain a solubilized hydrolyzed Psoralea corylifolia extract comprising mixing the unsolubilized hydrolyzed Psoralea corylifolia extract, bisabolol, and polysorbate 20 to obtain a thirteenth mixture, and adding the thirteenth mixture to the twelfth mixture at a temperature of less than about 40 degrees Celsius to obtain a fourteenth mixture, wherein the fourteenth mixture comprises the solubilized hydrolyzed Psoralea corylifolia extract;

mixing an encapsulated retinoid to the fourteenth mixture to obtain a fifteenth mixture;

allowing the fifteenth mixture to cool to about 35 degrees Celsius; and

obtaining an aqueous mixture that is a combination of the twelfth and thirteenth mixtures and the retinoid, wherein the aqueous mixture comprises a gel.

2 . The method of claim 1 wherein the retinoid comprises retinol.

3 . The method of claim 1 wherein the retinoid comprises tretinoin.

4 . The method of claim 1 wherein the retinoid comprises tazarotene.

5 . The method of claim 1 wherein the aqueous mixture comprises an antibiotic.

6 . The method of claim 5 wherein the antibiotic comprises clindamycin.

7 . The method of claim 5 wherein the antibiotic comprises erythromycin.

8 . The method of claim 1 comprising:

adding benzoyl peroxide to the polysorbate 20, bisabolol, and hydrolyzed Psoralea corylifolia extract of the thirteenth mixture.

9 . The method of claim 1 wherein the hydrolyzed Psoralea corylifolia extract comprises bakuchiol.

10 . The method of claim 1 wherein the aqueous mixture does not comprise an alcohol constituent.

11 . The method of claim 1 wherein the aqueous mixture does not comprise an oil constituent.

12 . The method of claim 1 wherein the solubilizing an unsolubilized hydrolyzed Psoralea corylifolia at a temperature of less than about 40 degrees Celsius results in a particle size of bakuchiol in the hydrolyzed Psoralea corylifolia extract that is of a sufficiently small size to penetrate skin pores into sebaceous follicles where the hydrolyzed Psoralea corylifolia extract can exert its antimicrobial and anti-inflammatory properties.

13 . A mixture comprising:

hydrolyzed Psoralea corylifolia extract;

bisabolol, wherein the hydrolyzed Psoralea corylifolia extract and bisabolol are solubilized together;

a retinoid; and

a surfactant, wherein the mixture is aqueous solution without oil and without an alcohol.

14 . The mixture of claim 13 further comprising at least one of benzoyl peroxide, tretinoin, tazarotene, or an antibiotic.

15 . The mixture of claim 14 wherein the antibiotic comprises at least one of clindamycin or erythromycin.

16 . The mixture of claim 13 wherein the retinoid comprises at least one of retinol, tretinoin, or tazarotene.

17 . The mixture of claim 13 wherein the retinoid is an encapsulated retinol.

18 . The mixture of claim 13 wherein the retinoid is an unencapsulated retinol, and the hydrolyzed Psoralea corylifolia extract, bisabolol, and unencapsulated retinol are solubilized together.

19 . The mixture of claim 13 wherein the surfactant comprises cocamidopropyl betaine having a weight-weight percentage greater than 10 percent.

20 . The mixture of claim 13 wherein the surfactant comprises decyl glucoside having a weight-weight percentage greater than 20 percent.